Literature DB >> 4074811

Antifertility effect of busulfan and procarbazine in male and female coyotes.

J N Stellflug, J S Green, C W Leathers.   

Abstract

Antifertility effects of two cytostatic agents, busulfan and procarbazine, were evaluated using 43 captive breeding pairs of adult coyotes. Nineteen pairs served as untreated controls. Only the male or female of remaining pairs was treated. Females received either 8 mg busulfan/kg or 6 mg procarbazine/kg just prior to onset of the breeding season. Males were treated once with either 8 mg busulfan/kg just before onset of breeding or with 4 mg busulfan/kg or 6 mg procarbazine/kg about 1 mo before onset of the breeding season. Uterine implantation sites were counted in females of all breeding pairs postpartum via laparotomy. Busulfan given to males at 4 mg/kg or to either females or males at 8 mg/kg significantly reduced implantation sites compared to untreated controls. Thus, busulfan may be successful in controlling population in coyotes in the field where both the male and female of a breeding pair may ingest the compound. However, multiple doses at a lower rate would be preferred because dosages greater than 10 mg/kg resulted in mortality. Although procarbazine has a mode of action similar to busulfan, doses of 6 mg procarbazine/kg did not reduce implantation sites or disrupt normal spermatogenesis. Increased doses need to be evaluated before effectiveness of procarbazine for coyote population control can be determined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074811     DOI: 10.1095/biolreprod33.5.1237

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  2 in total

1.  Optimal dose of busulfan for depleting testicular germ cells of recipient mice before spermatogonial transplantation.

Authors:  De-Zhi Wang; Xin-Hua Zhou; Yu-Lin Yuan; Xin-Min Zheng
Journal:  Asian J Androl       Date:  2009-12-14       Impact factor: 3.285

2.  Intraovarian transplantation of primordial follicles fails to rescue chemotherapy injured ovaries.

Authors:  Mi-Ryung Park; Yun-Jung Choi; Deug-Nam Kwon; Chankyu Park; Hong-Thuy Bui; Sangiliyandi Gurunathan; Ssang-Goo Cho; Hyuk Song; Han Geuk Seo; Gyesik Min; Jin-Hoi Kim
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.